Schroeder B, Yuan CM, Wang HW, Mohindroo C, et al. Phase 2 trial of rituximab with either pentostatin or bendamustine for multiply relapsed or refractory hairy cell leukemia. Blood 2025 Oct 8:blood.2025031243. doi: 10.1182/blood.2025031243.
PMID: 41060318